ALERS — Eurobio Scientific SA Income Statement
0.000.00%
Last trade - 00:00
- €161.64m
- €198.01m
- €152.61m
- 61
- 73
- 38
- 60
2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 50.5 | 59.1 | 189 | 185 | 153 |
Cost of Revenue | |||||
Gross Profit | 18.5 | 19.6 | 110 | 102 | 70.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 52.1 | 59 | 108 | 114 | 122 |
Operating Profit | -1.52 | 0.082 | 81.2 | 71.2 | 30.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.82 | 0.163 | 80.9 | 71.3 | 29.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.77 | 3.15 | 73.5 | 60.5 | 24.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.77 | 3.15 | 73.5 | 60.5 | 24.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.77 | 3.15 | 73.5 | 60.5 | 24.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.029 | 0.56 | 6.78 | 5.74 | 2.77 |
Dividends per Share |